FORM SC 13D

Company

Eloxx Pharmaceuticals, Inc.

Filed

April 13, 2021

Accession Number

0001062993-21-003594

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →